Novanta Inc (Novanta) is a global supplier of core technology solutions primarily serving medical, life science, and advanced industrial original equipment manufacturers (OEMs). The company combines proprietary technology expertise in medicine, manufacturing, robotics, and automation to engineer customized subsystems. It primarily serves customers across two end markets: the advanced industrial market and the medical market.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Novanta undertook several R&D initiatives in 2025, focusing on offering new innovations and improving lead times to customers. The company's new product pipeline is geared towards intelligent subsystems in strategic growth applications such as minimally invasive surgery, robotic surgery, next generation lithography, precision manufacturing applications, and precision motion solutions for robotics and automation applications. The R&D unit of Novanta Inc primarily comprises of employee compensation and related expenses and cost of materials for R&D projects. The unit is responsible for developing new innovations and improving lead times to customers, focusing on gaining content and share with intelligent subsystems into multiple high-growth application areas. In FY2025, the company spent US$95.4 million on its R&D activities, which accounted for 9.7% of the company’s revenue.